Latest news
Q3 EPS Estimates for Stoke Therapeutics Cut by HC Wainwright - MarketBeatMarketBeat · Thu, 06 Aug 2026 13:32:20 GMTStoke Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference - BioSpaceBioSpace · Thu, 06 Aug 2026 02:36:15 GMTStoke Therapeutics (NASDAQ:STOK) Earns Buy Rating from Guggenheim - MarketBeatMarketBeat · Tue, 04 Aug 2026 14:28:54 GMTStoke Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Updates - BioSpaceBioSpace · Tue, 04 Aug 2026 02:30:55 GMTStoke Therapeutics (NASDAQ: STOK) swings to H1 2026 loss as revenue falls - Stock TitanStock Titan · Mon, 03 Aug 2026 20:08:22 GMT